New Mexico Cancer Research Alliance
72
3
6
34
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 90/100
41.7%
30 terminated/withdrawn out of 72 trials
53.1%
-33.4% vs industry average
4%
3 trials in Phase 3/4
68%
23 of 34 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (72)
Progestins for the Treatment of Endometrial Cancer or Precancers of the Uterus Before Surgery, The Pro-Window Trial
Role: lead
Engagement of American Indians of Southwestern Tribal Nations in Cancer Genome Sequencing
Role: lead
Physical Activity Intervention for the Improvement of Pain in Young, Hispanic Breast Cancer Survivors
Role: lead
Enhancing Cancer Prevention and Control Pathways-Native Health Initiative
Role: lead
PARP-inhibition and CTLA-4 Blockade in BRCA-deficient Ovarian Cancer
Role: lead
Evaluation of GTPase Inhibition by Post-operative Intravenous Ketorolac in Ovarian Cancer Patients
Role: lead
Monitoring Response to Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer Using High-speed MR Spectroscopic Imaging
Role: lead
Expression & Epigenetic Silencing of MicroRNA for Predicting Therapeutic Response and Prognosis of HPV-negative HNSCC
Role: lead
Expanded Breast Cancer Registry and Tissue Repository
Role: lead
Exosome Testing as a Screening Modality for Human Papillomavirus-Positive Oropharyngeal Squamous Cell Carcinoma
Role: lead
Genome Sequencing of Human Cancer Tissues
Role: lead
Total Cancer Care Protocol: A Lifetime Partnership With Patients Who Have or May be at Risk of Having Cancer
Role: lead
Whole Brain Radiation Using IMRT for Patients With Brain Metastases
Role: lead
Laboratory Study of Cancer & Immune Cells in Ascites Fluid of Ovarian Cancer Patients to Test Alternative Therapies
Role: lead
Compassionate Use of BYL 719 Alpelisib
Role: lead
Acute Lymphoblastic Leukemia Therapies Informed by Genomic Analyses
Role: lead
Omega-3 Fatty Acid in Treating Pain in Patients With Breast or Ovarian Cancer Receiving Paclitaxel
Role: lead
Food Insecurity in Oncology
Role: lead
Breast Cancer Screening for Underserved Women: Comparing Outcomes and Lowering Recall Rates With 3D- vs. 2D-mammography
Role: lead
Sorafenib With Capecitabine for Patients With Measurable Hepatocellular Carcinoma
Role: lead